Royalty Pharma plc

Historical 13F Holders

Symbol
RPRX
CUSIP
G7709Q104
All holders as of
Q4 2024
Type
Equity
Class
SHS CLASS A
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 28 2.25 M $70.1 M
2024 Q4 424 320 M $8.18 B
2024 Q3 404 311 M $8.77 B
2024 Q2 389 368 M $9.71 B
2024 Q1 391 405 M $12.3 B
2023 Q4 375 369 M $10.4 B
2023 Q3 329 300 M $8.16 B
2023 Q2 336 319 M $9.31 B
2023 Q1 346 302 M $10.9 B
2022 Q4 350 307 M $12.1 B
2022 Q3 334 301 M $12.1 B
2022 Q2 297 292 M $12.3 B
2022 Q1 295 271 M $10.5 B
2021 Q4 284 268 M $10.7 B
2021 Q3 246 265 M $9.59 B
2021 Q2 253 250 M $10.3 B
2021 Q1 231 248 M $15.0 B
2020 Q4 218 231 M $13.4 B
2020 Q3 145 159 M $8.19 B
2020 Q2 127 150 M $8.96 B
2020 Q1 1 15.0 $1.00 k
2019 Q4 1 15.0 $1.00 k
2019 Q3 1 15.0 $1.00 k
2019 Q2 1 15.0 $1.00 k
2019 Q1 1 15.0 $1.00 k